Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin in hip adductors plus exercise for hereditary spastic paraplegia (pilot RCT)
2015-003184-11Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of neuronox in hereditary spastic paraplegia (HSP) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Success ratio of recovering balance by a lateral step, Frontal leg angle and 1 more. Started Oct 2015; status: completed.
02
Drugs
neuronox
03
Conditions
hereditary spastic paraplegia (HSP)
Beyond the preview
Go deeper on 2015-003184-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003184-11.